The Journal of Organic Chemistry · 2009 · 26 citations · 30 references
PharmacyBiochemistryMedicinal ChemistryDrug DiscoveryLead OptimizationStructure-activity RelationshipsEnzyme FunctionEnzyme InhibitionEnzyme ActivityHigh-throughput Screening AssaysLead Compound OptimizationLead Compound ScreeningPyrimidine AnaloguesSmall-molecule Library ConstructionSmall-molecule Library DesignStructural Analogue Identification
(E)-5-Nitro-6-(2-hydroxystyryl)pyrimidine-2,4(1H,3H)-dione (9) was identified as a novel inhibitor of Schizosaccharomyces pombe lumazine synthase by high-throughput screening of a 100000 compound library. The K(i) of 9 vs Mycobacterium tuberculosis lumazine synthase was 95 microM. Compound 9 is a structural analogue of the lumazine synthase substrate 5-amino-6-(d-ribitylamino)-2,4-(1H,3H)pyrimidinedione (1). This indicates that the ribitylamino side chain of the substrate is not essential for binding to the enzyme. Optimization of the enzyme inhibitory activity through systematic structure modification of the lead compound 9 led to (E)-5-nitro-6-(4-nitrostyryl)pyrimidine-2,4(1H,3H)-dione (26), which has a K(i) of 3.7 microM vs M. tuberculosis lumazine synthase.
30
K. Ritsert, Robert Huber, Rudolf Ladenstein et al. · Journal of Molecular Biology · 1995 · 130 citations